Skip to content

Hydromorphone Hydrochloride Epidural Preemptive Analgesia for Postoperative Pain After Cesarean Section

Clinical Effect of Hydromorphone Hydrochloride Epidural Preemptive Analgesia on Postoperative Pain After Cesarean Section

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06823180
Acronym
HHEPA
Enrollment
105
Registered
2025-02-12
Start date
2025-03-03
Completion date
2025-08-28
Last updated
2025-09-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post-surgical Pain

Brief summary

Acute pain often occurs after cesarean section, which can lead to stress and inflammatory response in the body, which will not only affect the postpartum recovery speed of the puerpera, but also inhibit the secretion of prolactin to a certain extent and reduce the secretion of milk. Epidural anesthesia is a common anesthesia method for cesarean section, which has the advantages of easy operation and little influence on the fetus. Preemptive analgesia can effectively block the transmission of harmful stimuli and reduce the degree of pain after cesarean section. Hydromorphone hydrochloride is a derivative of morphine, which has the advantages of rapid onset and good analgesic effect, and has been widely used in clinic. However, it is not clear whether epidural injection of hydromorphone hydrochloride for preanalgesia can bring clinical benefits to puerpera, and the optimal dose of hydromorphone hydrochloride for cesarean section is also unclear. The parturient women who met the inclusion criteria were randomly divided into 3 groups: control group, hydromorphone hydrochloride low-dose administration group and hydromorphone hydrochloride high-dose administration group. All women received epidural combined subarachnoid anesthesia. 15min before the end of the operation, the low-dose hydromorphone hydrochloride group was injected with 0.1mg hydromorphone hydrochloride in the epidural space, the high-dose hydromorphone hydrochloride group was injected with 0.3mg hydromorphone hydrochloride in the epidural space, and the control group was injected with 0.9% sodium chloride injection. Post-obstetric visual analogue scale (VAS) was followed up to record PCA compression times, gastrointestinal peristalsis recovery time, getting out of bed time, lactation time, and related adverse reactions.

Interventions

DRUGHydromorphone hydrochloride low dose

15min before the end of the operation, 0.1mg hydromorphone hydrochloride was injected into the epidural space in the low-dose group for preemptive analgesia.

DRUGHydromorphone hydrochloride high dose

15min before the end of the operation, 0.3mg hydromorphone hydrochloride was injected into the epidural space in the high-dose group for preemptive analgesia.

DRUG0.9% sodium chloride

15min before the end of the operation, 0.9% sodium chloride injection was given in the control group.

Sponsors

Liquan Liang
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
22 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

* Parturients with indications for cesarean section; * American Association of Anesthesiologists (ASA) Grade I - II; * No history of sedative drugs or opioid abuse; * Volunteer to join the study

Exclusion criteria

* People with coagulation disorders; * preoperative use of analgesia, non-steroidal drugs; * Abnormal liver and kidney function; * Postoperative drainage is urgently needed.

Design outcomes

Primary

MeasureTime frameDescription
VAS score24 hours after surgeryVAS score was used to evaluate the pain in each period after obstetric surgery. A strip marked with a scale of 0-10 was taken, where 0 indicated no pain, the pain degree increased with the increase of the score, and 10 indicated the most pain. The mothers chose the score matching their own pain degree. Mild pain: 0\<VAS\<4 ; Moderate pain :4 ≤VAS\< 7; Severe pain :7 ≤VAS\<9; Extreme pain: VAS≥9.

Secondary

MeasureTime frameDescription
Satisfaction evaluationBefore dischargePatients' satisfaction was assessed by HCAHPS survey. The survey was designed to assess patient inpatient experience, including nurse care, physician communication, hospital environment, hospital experience, discharge information provision, and overall hospital evaluation.
Gastrointestinal peristalsis recovery time72 hours after surgeryThe recovery time of bowel sound, anal exhaust and defecation were recorded.
The time it takes to get out of bed for the first time after surgery96 hours after surgery
The number of PCA compressions after surgery48 hours after surgery
Postoperative nausea and vomiting(PONV)72 hours after surgeryPONV rating standards of WHO are adopted. Specifically: Grade I is no nausea, vomiting; Grade II was mild nausea, abdominal discomfort, but no vomiting; Grade III is nausea and vomiting, but there is no content spit out; Grade IV is severe vomiting, with vomiting of stomach contents and requiring medical control.
pruritus72 hours after surgeryThe numeric rating scale (NRS) was used to evaluate the degree of postoperative pruritus. Itching is numerically graded on the NRS scale, with 0 indicating no itching and 10 indicating the most severe itching. The degree of itching increased with the increase of the score. Mild pruritus :0\<NRS\<4 ; Moderate pruritus :4 ≤NRS\< 7; Severe pruritus :7 ≤NRS\<9; Extreme pruritus :NRS≥9.
The time between the end of surgery and lactation72 hours after surgery

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026